Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does treatment with rosiglitazone reduce the incidence of diabetes in individuals with impaired glucose regulation?

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Joslin E (1921) The prevention of diabetes mellitus. JAMA 76: 79–84

    Article  Google Scholar 

  2. Tuomilehto J and Lindström J (2003) The major diabetes prevention trials. Curr Diab Rep 3: 115–122

    Article  Google Scholar 

  3. Simpson RW et al. (2004) Prevention of type 2 diabetes mellitus. In International Textbook of Diabetes Mellitus, edn 3 (2 vols) 1899–1913 (Eds De Fronzo RA et al.) Chichester: John Wiley & Sons Ltd

    Google Scholar 

  4. Buchanan TA et al. (2002) Preservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes 51: 2796–2803

    Article  CAS  Google Scholar 

  5. Lindström J et al. (2006) Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 368: 1673–1679

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Vicky Heath, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tuomilehto, J. Does treatment with rosiglitazone reduce the incidence of diabetes in individuals with impaired glucose regulation?. Nat Rev Endocrinol 3, 212–213 (2007). https://doi.org/10.1038/ncpendmet0422

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpendmet0422

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing